Futura Medical plc
Futura Medical plc, a pioneering healthcare company based in Great Britain, focuses on the development of innovative products for the treatment of sexual health and pain management. Founded in 2001, the company has made significant strides in the pharmaceutical and medical device sectors, particularly with its proprietary transdermal technology. Futura Medical is renowned for its flagship product, MED3000, a topical gel designed to enhance erectile function, which sets it apart in the competitive sexual health market. The company’s commitment to research and development has positioned it as a leader in its field, with a strong emphasis on safety and efficacy. With a growing portfolio and strategic partnerships, Futura Medical continues to advance its mission of improving patient outcomes while solidifying its presence in the global healthcare landscape.
DitchCarbon Score
How does Futura Medical plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Futura Medical plc's score of 17 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Futura Medical plc's reported carbon emissions
In 2023, Futura Medical plc reported total gross emissions of approximately 230.0 kg CO2e per pupil, while in 2024, this figure decreased to about 200.0 kg CO2e per pupil. These emissions are classified under a scope that is not specifically defined, indicating a lack of detailed categorisation into Scope 1, 2, or 3 emissions. Despite these figures, Futura Medical plc has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. There are no commitments to the Science Based Targets initiative (SBTi) or other climate pledges, and no emissions data has been cascaded from a parent or related organisation. Overall, while Futura Medical plc has shown a reduction in emissions per pupil over the two years, the absence of formal climate commitments or detailed emissions reporting suggests that further transparency and strategic planning may be necessary to enhance their climate action efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Futura Medical plc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
